Chongqing Genrix Biopharmaceutical Co., Ltd.

¥26.59As of Sun 8 Nov 2026, 12:00 UTC
SSE:688443Healthcare
Country China
PE (Fwd) •••
TSR 3Y CAGR (4.38%)
Div yield —
ROE (12.33%)
Biotechnology
Beta (5Y) 0.65
PE TTM —
TSR TTM (12.30%)
Mkt cap ¥9.750B
ROIC (5.27%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥28
5.85%
236.46%
Hold 12|8|6|11|6
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.35
0.35
0.34
0.33
16.42%
13.62%
6.35%
7.13%
Revenue¥M
556.6
561.9
563.4
586.8
0.18%
(0.50%)
1.40%
3.46%
Peers (US$1.457B)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
3.751
0.719
0.671
EBIT/Intx
0.165
1.477
1.141
Own earn%
17.61
(83.13)
(55.95)
Sh yield%
23.13
14.78
12.02
Owners
Insiders/Inst%
3.83
59.32
Short interest%
1.86
SBC / revenue%
3.26
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
0–4
$1 testx
0.2
Incr. ROIC%
10